VIAF

Virtual International Authority File

Search

Leader     00000nz a2200037n 45 0
001     WKP|Q80408054  (VIAF cluster)  (Authority/Source Record)
003     WKP
005     20241221010855.0
008     241221nneanz||abbn n and d
035 ‎‡a  (WKP)Q80408054‏
024 ‎‡a  0000-0001-6050-7354‏ ‎‡2  orcid‏
024 ‎‡a  23501529300‏ ‎‡2  scopus‏
035 ‎‡a  (OCoLC)Q80408054‏
100 0 ‎‡a  P Cabrera Roldán‏ ‎‡c  researcher‏ ‎‡9  en‏
400 0 ‎‡a  P Cabrera Roldán‏ ‎‡c  wetenschapper‏ ‎‡9  nl‏
670 ‎‡a  Author's Evidence-based estimation and radiotherapy utilisation rate in Andalusia‏
670 ‎‡a  Author's Genetic variations in genes involved in testosterone metabolism are associated with prostate cancer progression: A Spanish multicenter study.‏
670 ‎‡a  Author's Health related quality of life and late side effects of long-term survivors of Ewing's sarcoma of bone‏
670 ‎‡a  Author's Intraethnic variation in steroid-5-alpha-reductase polymorphisms in prostate cancer patients: a potential factor implicated in 5-alpha-reductase inhibitor treatment‏
670 ‎‡a  Author's Myeloablative therapy against high risk Ewing's sarcoma: A single institution experience and literature review‏
670 ‎‡a  Author's Prognostic factors for overall survival in paediatric patients with Ewing sarcoma of bone treated according to multidisciplinary protocol‏
670 ‎‡a  Author's Role of radiation therapy in the multidisciplinary management of Ewing's Sarcoma of bone in pediatric patients: An effective treatment for local control‏
670 ‎‡a  Author's Single nucleotide polymorphisms in DNA repair genes as risk factors associated to prostate cancer progression‏
909 ‎‡a  (scopus) 23501529300‏ ‎‡9  1‏
909 ‎‡a  (orcid) 0000000160507354‏ ‎‡9  1‏
919 ‎‡a  singlenucleotidepolymorphismsindnarepairgenesasriskfactorsassociatedtoprostatecancerprogression‏ ‎‡A  Single nucleotide polymorphisms in DNA repair genes as risk factors associated to prostate cancer progression‏ ‎‡9  1‏
919 ‎‡a  prognosticfactorsforoverallsurvivalinpaediatricpatientswithewingsarcomaofbonetreatedaccordingtomultidisciplinaryprotocol‏ ‎‡A  Prognostic factors for overall survival in paediatric patients with Ewing sarcoma of bone treated according to multidisciplinary protocol‏ ‎‡9  1‏
919 ‎‡a  myeloablativetherapyagainsthighriskewingssarcomaasingleinstitutionexperienceandliteraturereview‏ ‎‡A  Myeloablative therapy against high risk Ewing's sarcoma: A single institution experience and literature review‏ ‎‡9  1‏
919 ‎‡a  intraethnicvariationinsteroid5alphareductasepolymorphismsinprostatecancerpatientsapotentialfactorimplicatedin5alphareductaseinhibitortreatment‏ ‎‡A  Intraethnic variation in steroid-5-alpha-reductase polymorphisms in prostate cancer patients: a potential factor implicated in 5-alpha-reductase inhibitor treatment‏ ‎‡9  1‏
919 ‎‡a  healthrelatedqualityoflifeandlatesideeffectsoflongtermsurvivorsofewingssarcomaofbone‏ ‎‡A  Health related quality of life and late side effects of long-term survivors of Ewing's sarcoma of bone‏ ‎‡9  1‏
919 ‎‡a  geneticvariationsingenesinvolvedintestosteronemetabolismareassociatedwithprostatecancerprogressionaspanishmulticenterstudy‏ ‎‡A  Genetic variations in genes involved in testosterone metabolism are associated with prostate cancer progression: A Spanish multicenter study.‏ ‎‡9  1‏
919 ‎‡a  evidencebasedestimationandradiotherapyutilisationrateinandalusia‏ ‎‡A  Evidence-based estimation and radiotherapy utilisation rate in Andalusia‏ ‎‡9  1‏
919 ‎‡a  roleofradiationtherapyinthemultidisciplinarymanagementofewingssarcomaofboneinpediatricpatientsaneffectivetreatmentforlocalcontrol‏ ‎‡A  Role of radiation therapy in the multidisciplinary management of Ewing's Sarcoma of bone in pediatric patients: An effective treatment for local control‏ ‎‡9  1‏
996 ‎‡2  BNE|XX5532896
996 ‎‡2  JPG|500026070
996 ‎‡2  JPG|500037303
996 ‎‡2  LC|nb2014027567
996 ‎‡2  DNB|1057355682
996 ‎‡2  BNE|XX849338
996 ‎‡2  BLBNB|000515551
996 ‎‡2  BNE|XX5346472
996 ‎‡2  DNB|1161825843
996 ‎‡2  SUDOC|255433743
996 ‎‡2  SUDOC|057518076
996 ‎‡2  J9U|987012502448605171
996 ‎‡2  BNF|18066622
996 ‎‡2  ISNI|0000000510851631
996 ‎‡2  ISNI|0000000059226013
996 ‎‡2  LC|no2016027244
996 ‎‡2  DNB|1195228546
996 ‎‡2  BIBSYS|98070944
996 ‎‡2  BNC|981058512161606706
996 ‎‡2  ISNI|0000000046749392
996 ‎‡2  DNB|1057709417
996 ‎‡2  BNF|13201654
996 ‎‡2  LC|n 84076373
996 ‎‡2  RERO|A018425162
996 ‎‡2  LC|no2009035700
996 ‎‡2  ISNI|0000000444631349
996 ‎‡2  LC|n 2003098577
996 ‎‡2  ISNI|0000000457168410
996 ‎‡2  LC|n 2012035223
996 ‎‡2  BNE|XX6082102
996 ‎‡2  BNE|XX912163
996 ‎‡2  DNB|1157166709
996 ‎‡2  SZ|170853381
996 ‎‡2  ISNI|0000000443607689
996 ‎‡2  ISNI|0000000037323680
996 ‎‡2  LC|no 97070619
996 ‎‡2  DNB|1055807233
996 ‎‡2  LIH|LNB:DTFP;=BK
996 ‎‡2  ISNI|0000000066385661
996 ‎‡2  ISNI|000000003531561X
996 ‎‡2  RERO|A003366867
996 ‎‡2  BNC|981058611981306706
996 ‎‡2  BNC|981058527875906706
996 ‎‡2  DNB|143852353
996 ‎‡2  BNE|XX5297678
996 ‎‡2  BNE|XX1041398
996 ‎‡2  BNE|XX6040509
996 ‎‡2  BNCHL|10000000000000000138350
996 ‎‡2  JPG|500016834
996 ‎‡2  ISNI|0000000408528010
996 ‎‡2  LC|no2022022682
996 ‎‡2  LC|n 96029070
996 ‎‡2  LC|n 2001039479
997 ‎‡a  0 0 lived 0 0‏ ‎‡9  1‏